Thomas A. Penfound
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thomas A. Penfound has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- James B. Dale
University of Tennessee Health Science Center
2 shared publications Jeremy C. Smith
Department of Biochemistry and Cellular and Molecular Biology, University of Tennessee, Knoxville, TN 37996, United States; UT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, TN 37830, United States
2 shared publicationsSanaz Salehi
Department of Medicine, Division of Infectious Diseases, University of Tennessee Health Science Center, Memphis, TN 38163, United States
2 shared publications- Adam Greeley
Department of Medicine, Immunology and Biochemistry, The University of Tennessee Health Science Center, Memphis, TN, USA.; Department of Medicine, Veterans Affairs Medical Center, Memphis, TN, USA
1 shared publication - Claudia M. Hohn
Department of Medicine, Immunology and Biochemistry, The University of Tennessee Health Science Center, Memphis, TN, USA.; Department of Medicine, Veterans Affairs Medical Center, Memphis, TN, USA
1 shared publication - Harry S. Courtney
Department of Medicine, Immunology and Biochemistry, The University of Tennessee Health Science Center, Memphis, TN, USA.; Department of Medicine, Veterans Affairs Medical Center, Memphis, TN, USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2017
- Published by XMLink in Clinical and Experimental Vaccine Research
- Vol. 6 (1) , 45-49
Trivalent M-related protein as a component of next generation group A streptococcal vaccines
Courtney HS, et al. Clin Exp Vaccine Res. 2017 Jan;6(1):45-49. https://doi.org/10.7774/cevr.2017.6.1.45
- 1 January 2017
- Published by XMLink in Clinical and Experimental Vaccine Research
- Vol. 6 (1) , 45-49
Open AccessTrivalent M-related protein as a component of next generation group A streptococcal vaccines
Courtney HS, et al. Clin Exp Vaccine Res. 2017 Jan;6(1):45-49. https://doi.org/10.7774/cevr.2017.6.1.45